ARCHIVES

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: Balch To Head City of Hope; Rowinsky Moves To San Antonio; Klausner’s Deputy Joins NCI

August 9, 1996

Murray Copeland Display Dedicated

March 18, 1983

NIH Limits Salaries On Grants, Contracts ACS Clinical Awards Available For 1995

February 25, 1994

CGAP Speeding Gene Discovery

April 30, 1999

Center Grant Review Tougher, Yarbro Insists

May 23, 1975

In Brief: Yale Names DeVita Center Director; Canellos, Anrman Lead ASCO; Bresnick To Head AACR

June 4, 1993